resveratrol has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, BY; DiRenzo, D; Goel, SA; Guo, LW; Ke, J; Kent, A; Kent, KC; Li, L; Little, C; Murphy, WL; Roenneburg, DA; Shi, XD; Shi, Y; Takayama, T; Urabe, G; Wang, B; Zhang, M; Zhou, Y; Zhu, Y | 1 |
| Park, K | 1 |
2 other study(ies) available for resveratrol and Coronary Restenosis
| Article | Year |
|---|---|
Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol.
Topics: Animals; Antioxidants; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Gene Expression Regulation; Male; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Smad3 Protein; Stilbenes; Transforming Growth Factor beta | 2017 |
Dual drug-eluting stent.
Topics: Animals; Cardiotonic Agents; Coronary Restenosis; Coronary Thrombosis; Delayed-Action Preparations; Drug-Eluting Stents; Humans; Quercetin; Resveratrol; Stilbenes | 2012 |